Torres, Cristian Gabriel <br/><br/>
A cyclized peptide derived from alpha fetoprotein inhibits the proliferation of ER-positive canine mammary cancer cells.  [electronic resource] 

 -  Oncology reports  Jun 2009 
 - 1397-404 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1021-335X 
<br/><br/><label>Standard No.: </label>10.3892/or_00000367  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Proliferation--drug effects<br/>Dogs<br/>Epidermal Growth Factor--metabolism<br/>Estradiol--metabolism<br/>Estrogen Antagonists--pharmacology<br/>Estrogen Receptor alpha--drug effects<br/>Estrogen Receptor beta--drug effects<br/>Female<br/>Heparin-binding EGF-like Growth Factor<br/>Intercellular Signaling Peptides and Proteins--metabolism<br/>Mammary Neoplasms, Animal--metabolism<br/>Matrix Metalloproteinase 2--metabolism<br/>Matrix Metalloproteinase 9--metabolism<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Mitogen-Activated Protein Kinase 3--metabolism<br/>Neoplasm Staging<br/>Peptides, Cyclic--pharmacology<br/>Phosphorylation<br/>Receptor, ErbB-2--metabolism<br/>Signal Transduction--drug effects<br/>Tamoxifen--pharmacology<br/>Tumor Cells, Cultured<br/>alpha-Fetoproteins--pharmacology